Skip to content
healthcare.dev

Azacitidine

NDC 16729-306, Azacitidine, injection, powder, lyophilized, for solution, from Accord Healthcare Inc..

Product NDC
16729-306
Status
Listed
Labeler
Accord Healthcare Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207475
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16729-306 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZACITIDINE100 mg/1

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
16729-306-10167290306101 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (16729-306-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/70140e11-33f1-2240-e053-2991aa0a0480
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=16729-306

Use it

Look up 16729-306 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16729-306 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16729-306. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.